Precursor B-cell Acute Lymphoblastic Leukemia Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2024-10-24
EMA Authorised: Jylamvo (methotrexate) — Oresund Pharma ApS
The European Medicines Agency authorised Jylamvo, a methotrexate product from Oresund Pharma ApS, for indications including psoriatic arthri…